RON Receptor-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Long-term Tumor Regressions in Preclinical Models of Triple-Negative Breast Cancer (TNBC)

被引：0
|
作者：
Suthe, Sreedhar Reddy
Yao, Hang-Ping
Wang, Ming-Hai
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
510.3
引用
收藏
页数：2
相关论文
共 50 条
  • [1] RON-Targeted Antibody-Drug Conjugate Therapy Ablates Cancer Stem Cells and Induces Longterm Tumor Regressions in Preclinical Models of Triple Negative Breast Cancer
    Suthe, S.
    Yao, H.
    Wang, M.
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (10): : 2411 - 2412
  • [2] RON-targeted antibody-drug conjugate therapy eliminates cancer stem-like cells and induces long-term tumor regressions in preclinical models of triple-negative breast cancer.
    Suthe, Sreedhar Reddy
    Yao, Hang-Ping
    Wang, Ming-Hai
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 108 - 108
  • [3] Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC)
    Gupta, Gaurav
    Hussain, Md Sadique
    Pant, Kumud
    Ali, Haider
    Thapa, Riya
    Bhat, Asif Ahmad
    CURRENT CANCER DRUG TARGETS, 2025, 25 (02) : 108 - 112
  • [4] Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy
    Si, Yingnan
    Xu, Yuanxin
    Guan, JiaShiung
    Chen, Kai
    Kim, Seulhee
    Yang, Eddy S.
    Zhou, Lufang
    Liu, Xiaoguang Margaret
    ENGINEERING IN LIFE SCIENCES, 2021, 21 (1-2): : 37 - 44
  • [5] New Biomarkers in a Novel Antibody-Drug Conjugate for Triple-Negative Breast Cancer
    Nagayama, Aiko
    ONCOLOGIST, 2018, 23 : S5 - S5
  • [6] RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells
    Suthe, Sreedhar Reddy
    Yao, Hang-Ping
    Weng, Tian-Hao
    Wang, Ming-Hai
    CURRENT CANCER DRUG TARGETS, 2023, 23 (02) : 103 - 117
  • [7] Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
    A. Thakkar
    B. Wang
    M. Picon-Ruiz
    P. Buchwald
    Tan A. Ince
    Breast Cancer Research and Treatment, 2016, 157 : 77 - 90
  • [8] Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
    Thakkar, A.
    Wang, B.
    Picon-Ruiz, M.
    Buchwald, P.
    Ince, Tan A.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (01) : 77 - 90
  • [9] Sacituzumab govitecan: a new antibody-drug conjugate for metastatic triple-negative breast cancer
    Banys-Paluchowski, M.
    Krawczyk, Natalia
    ONKOLOGE, 2021, 27 (03): : 287 - 290
  • [10] IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results
    Goldenberg, David M.
    Vahdat, Linda T.
    Starodub, Alexander N.
    Bardia, Aditya
    Chuang, Ellen
    Moroose, Rebecca L.
    Diamond, Jennifer R.
    Sharkey, Robert M.
    Maliakal, Pius P.
    Hamburger, Steven A.
    Ocean, Allyson J.
    CANCER RESEARCH, 2015, 75
12345